Findings show protection for all variant periods
Paxlovid Soon Will Not Be Free for Americans
At this point, about 6 million Americans have taken free Paxlovid doses
SGLT-2i Use Before COVID-19 May Reduce Adverse Outcomes in Diabetes Patients
SGLT-2is associated with lowest probability for adverse outcomes followed by glucagon-like peptide-1 receptor agonists, metformin